The pharmaceutical and biotechnology company Moderna, Inc. (MRNA) has collaborated with Tabuk Pharmaceuticals to market its COVID-19 Vaccine and future, variant-specific booster candidates, in Saudi Arabia. Shares of the company declined 1.3% in Friday’s extended trading session. The financial terms of the deal have not been disclosed. Per the agreement, Tabuk could get the opportunity to distribute other authorized Moderna mRNA products in the future. Tabuk Pharmaceuticals, a fully-owned subsidiary of Astra Industrial Group, is a Saudi pharmaceuticals company. Moderna CEO Stephane Bancel said, “We appreciate the collaboration of Tabuk Pharmaceuticals in this new partnership in Saudi Arabia.
https://www.tipranks.com/news/moderna-inks-partnership-deal-with-tabuk-pharmaceuticals
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Moderna Charts.